High pretreatment serum PSA and tumour hypoxia (high GLUT-1 expression or lower VEGF and lower nuclear hTERT expression) were negative prognosticators for biochemical recurrence-free survival in PCa patients after radical prostatectomy. The gene discussed is SLC2A1; the disease is posterior cortical atrophy.